Table 3. Process outcomes.
| Post v Pre SBL | Full v no implementation * | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Source | Trusts | Women | Pre | Post | RRpost | P | RR | P | |
| Element 1 | Smoking Cessation | ||||||||
| Smoking at Delivery | Women† | 19 | 2,085 | - | 10.1 | - | - | 1.21 (0.67–2.19) | 0.50 |
| Smoking at Delivery | Electronic Data | 14 | 268,736 | 14.3 | 11.8 | 0.83 (0.80–0.86) | <0.001 | 0.91 (0.44–1.86) | 0.80 |
| Offered CO test | Women† | 19 | 1,870 | - | 70.1 | - | - | 7.95 (5.17–12.23) | <0.001 |
| Referred to smoking cessation | Women† | 19 | 311 | - | 60.1 | - | - | 1.11 (0.41–2.98) | 0.82 |
| Ceased Smoking | Women† | 19 | 331 | - | 40.8 | - | - | 0.70 (0.28–1.76) | 0.42 |
| Ceased Smoking | Electronic Data | 11 | 27,550 | 28.7 | 27.0 | 0.94 (0.87–1.01) | 0.098 | 3.99 (0.80–19.99) | 0.11 |
| Smoked in Pregnancy | Women† | 19 | 2,158 | - | 15.7 | - | - | 1.15 (0.71–1.86) | 0.55 |
| Smoking at Booking | Electronic Data | 11 | 203,635 | 16.2 | 14.1 | 0.87 (0.84–0.90) | <0.001 | 0.50 (0.25–1.02) | 0.070 |
| Element 2 | Detection and Management of SGA fetus | ||||||||
| SGA detected | SGA Audit | 17 | 636 | 33.8 | 53.7 | 1.59 (1.32–1.92) | <0.001 | 1.16 (0.34–4.01) | 0.79 |
| Growth chart in records | General Audit | 18 | 720 | - | 97.8 | - | - | 1.21 (0.17–8.80) | 0.84 |
| EFW plotted | SGA Audit | 17 | 636 | 24.7 | 75.7 | 3.06 (2.48–3.76) | <0.001 | 38.24 (7.80–187.46) | <0.001 |
| EFW plotted correctly | SGA Audit | 17 | 582 | 99.2 | 99.1 | 1.00 (0.98–1.01) | 0.80 | Insufficient Data | - |
| SFH plotted | SGA Audit | 17 | 636 | 35.5 | 47.8 | 1.35 (1.11–1.63) | 0.002 | 5.07 (1.42–18.11) | 0.005 |
| Element 3 | Fetal Movements | ||||||||
| RFM leaflet received | Women† | 19 | 1,735 | - | 74.4 | - | - | 2.87 (1.98–4.17) | <0.001 |
| RFM checklist used | RFM Audit | 17 | 339 | - | 52.2 | - | - | 0.44 (0.22–0.88) | 0.010 |
| Attendances for RFM | Women† | 19 | 2,171 | - | 36.5 | - | - | 0.95 (0.70–1.28) | 0.70 |
| Scan after RFM (any) | RFM Audit | 17 | 322 | - | 64.9 | - | - | 0.54 (0.25–1.17) | 0.080 |
| Scan for RFM | Women† | 19 | 793 | - | 29.4 | - | - | 0.85 (0.49–1.46) | 0.52 |
| Heart Monitoring every RFM visit | RFM Audit | 17 | 339 | - | 97.3 | - | - | 0.28 (0.03–2.82) | 0.18 |
| Heart Trace for RFM | Women† | 19 | 793 | - | 73.5 | - | - | 0.81 (0.46–1.43) | 0.42 |
| Induced following RFM | RFM Audit | 17 | 338 | - | 54.7 | - | - | 4.78 (2.29–9.95) | <0.001 |
| Element 4 | Fetal Monitoring | ||||||||
| Buddy and Sticker used | General Audit | 18 | 527 | - | 50.3 | - | - | 33.00 (10.85–100.39) | <0.001 |
| Escalation Protocol used | General Audit | 18 | 224 | - | 98.7 | - | - | Insufficient Data | - |
Columns show the data source, the number of Trusts and women providing data, the fitted pre and* post implementation rates (±2y from the SBL launch date), the post v pre risk ratio (with 95% CI and significance level) and the risk ratio associated with 100% implementation of the relevant SBL element.
* Adjusted for care level, IMD and calendar month.
†Women–refers to data obtained via the postnatal questionnaire of women undertaken in the postnatal period.